ArticleBiomolecules & therapeutics2026
Proarrhythmic Risk Assessment of Sildenafil under High-Dose Misuse Conditions Using the Comprehensive In Vitro Proarrhythmia Assay (CiPA).
Hanbi Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.